GNFC Q3 FY26: PAT at 150 Cr, new MD appointed, DoT demand flagged
GNFC · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.0 pts less than Nifty Microcap 250 and 2.2 pts less than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
GNFC reported Q3 FY26 standalone revenue of 1,996 Cr vs 1,899 Cr YoY, with PAT at 150 Cr vs 158 Cr. For 9M FY26, revenue declined to 5,565 Cr from 5,837 Cr, but PAT rose to 405 Cr from 375 Cr. Board appointed Rajkumar Beniwal, IAS as new MD and Dr Rajender Kumar, IAS as Director, subject to shareholder approval via postal ballot. RPT policy was also revised. The auditor flagged a 21,370 Cr DoT demand as an emphasis of matter, though no provision was made.
Mixed Q3 with steady profits, key management change, and a large contingent DoT demand flagged by auditors for shareholders to track.